tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

JAZZ Stock Latest News

Booking, Carvana upgraded: Wall Street’s top analyst calls
The FlyBooking, Carvana upgraded: Wall Street’s top analyst calls
5d ago
H
MS
Jazz Pharmaceuticals downgraded to Neutral from Buy at UBS
PremiumThe Fly
Jazz Pharmaceuticals downgraded to Neutral from Buy at UBS
5d ago
JAZZ
Hold Rating for Jazz Pharmaceuticals Amid Balanced Risk-Reward and Competitive Challenges
PremiumRatings
Hold Rating for Jazz Pharmaceuticals Amid Balanced Risk-Reward and Competitive Challenges
5d ago
JAZZ
Zymeworks price target raised to $40 from $30 at Stifel
PremiumThe Fly
Zymeworks price target raised to $40 from $30 at Stifel
10d ago
JAZZ
ZYME
Strong Buy Rating for Jazz Pharmaceuticals Driven by Promising Ziihera Drug and Positive Market Outlook
PremiumRatings
Strong Buy Rating for Jazz Pharmaceuticals Driven by Promising Ziihera Drug and Positive Market Outlook
10d ago
JAZZ
Truist ups Jazz Pharmaceuticals price target, says Ziihera is pipeline-in-a drug
PremiumThe FlyTruist ups Jazz Pharmaceuticals price target, says Ziihera is pipeline-in-a drug
10d ago
JAZZ
Jazz Pharmaceuticals price target raised to $209 from $160 at Baird
Premium
The Fly
Jazz Pharmaceuticals price target raised to $209 from $160 at Baird
11d ago
JAZZ
Jazz Pharmaceuticals price target raised to $247 from $230 at BofA
Premium
The Fly
Jazz Pharmaceuticals price target raised to $247 from $230 at BofA
11d ago
JAZZ
Jazz Pharmaceuticals price target raised to $235 from $170 at Wells Fargo
PremiumThe Fly
Jazz Pharmaceuticals price target raised to $235 from $170 at Wells Fargo
11d ago
JAZZ
Jazz Pharmaceuticals’ Promising Pipeline and Strong Trial Results Lead to Buy Rating and Raised Price Objective
PremiumRatings
Jazz Pharmaceuticals’ Promising Pipeline and Strong Trial Results Lead to Buy Rating and Raised Price Objective
11d ago
JAZZ
Zymeworks Stock (ZYME) Soars on Positive Results for Cancer Drug Ziihera, Top Analysts Boost Price Targets
PremiumMarket News
Zymeworks Stock (ZYME) Soars on Positive Results for Cancer Drug Ziihera, Top Analysts Boost Price Targets
11d ago
ONC
JAZZ
Jazz Pharmaceuticals price target raised to $225 from $185 at Jefferies
PremiumThe Fly
Jazz Pharmaceuticals price target raised to $225 from $185 at Jefferies
11d ago
JAZZ
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
PremiumMarket NewsMorning News Wrap-Up: Monday’s Biggest Stock Market Stories!
12d ago
HD
KO
Jazz Pharmaceuticals rises 20.6%
Premium
The Fly
Jazz Pharmaceuticals rises 20.6%
12d ago
JAZZ
Jazz Pharmaceuticals price target raised to $194 from $155 at RBC Capital
Premium
The Fly
Jazz Pharmaceuticals price target raised to $194 from $155 at RBC Capital
12d ago
JAZZ
Promising Phase 3 Trial Results and Expanding Indications Drive Buy Rating for Jazz Pharmaceuticals
PremiumRatings
Promising Phase 3 Trial Results and Expanding Indications Drive Buy Rating for Jazz Pharmaceuticals
12d ago
JAZZ
Jazz Pharmaceuticals price target raised to $205 from $185 at Morgan Stanley
PremiumThe Fly
Jazz Pharmaceuticals price target raised to $205 from $185 at Morgan Stanley
12d ago
ONC
JAZZ
Jazz Pharmaceuticals rises 20.8%
PremiumThe Fly
Jazz Pharmaceuticals rises 20.8%
12d ago
JAZZ
Jazz Pharmaceuticals Stock Surges on Positive Phase 3 Trial Results
PremiumMarket News
Jazz Pharmaceuticals Stock Surges on Positive Phase 3 Trial Results
12d ago
JAZZ
Promising HERIZON-GEA Trial Results Drive Buy Rating for Jazz Pharmaceuticals’ Ziihera
PremiumRatingsPromising HERIZON-GEA Trial Results Drive Buy Rating for Jazz Pharmaceuticals’ Ziihera
12d ago
JAZZ
Jazz Pharmaceuticals Announces Positive Phase 3 Trial Results
Premium
Company Announcements
Jazz Pharmaceuticals Announces Positive Phase 3 Trial Results
12d ago
8K
JAZZ
Jazz Pharmaceuticals announces top-line results from HERIZON-GEA-01 trial
Premium
The Fly
Jazz Pharmaceuticals announces top-line results from HERIZON-GEA-01 trial
12d ago
JAZZ

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >